ALT flares were linked to HBsAg reduction, seroclearance and seroconversion: interim results from a phase IIb study in chronic hepatitis B patients with 24-week treatment of subcutaneous PD-L1 Ab ASC22 (Envafolimab) plus nucleos (t)ide analogsGuiqiang Wang, Jinzi J. Wu, Yimin Cui et al.|Journal of Hepatology|2022Cited by 20
Minimizing state-of-health degradation in hybrid electrical energy storage systems with arbitrary source and load profilesYanzhi Wang, Massoud Pedram, Lin Xue et al.|Unknown|2014Cited by 8
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)Jinlin Hou, Tarik Asselah, Cheng‐Yuan Peng et al.|Journal of Hepatology|2024Cited by 8
Clinical characteristics and pathogen spectra of parasitic infections in a tertiary hospital of Shanghai: A 13-year retrospective studyJinming Zhang, Xiaogang Xiang, Jing Xu et al.|Frontiers in Public Health|2022Cited by 5
Nosocomial infections in cirrhosis are unpredictable and vary based on region of the world: CLEARED studyJasmohan S. Bajaj, Anil Anora, F. Susan Wong et al.|Journal of Hepatology|2023Cited by 0